Mortality in ANCA-associated vasculitis: ameta-analysis of observational studies

2017/05/04 by Ju Tan, Ju Ann Tan, Natasha Dehghan +6 · 25 citations
Medicine · #Vasculitis and related conditions #Systemic Sclerosis and Related Diseases #Rheumatoid Arthritis Research and Therapies

paper · doi:10.1136/annrheumdis-2016-210942

Citations

• Long-term patient survival in ANCA-associated vasculitis

Cited by

• The Effect of Statin Use on Mortality in Systemic Autoimmune Rheumatic Diseases. [europepmc]
• Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in Korea: A Narrative Review. [europepmc]
• Fibrosis-4 index at diagnosis is associated with all-cause mortality in patients with microscopic polyangiitis and granulomatosis with polyangiitis. [europepmc]
• Multivariable index for assessing the activity and predicting all-cause mortality in antineutrophil cytoplasmic antibody-associated vasculitis. [europepmc]
• Controlling Nutritional Status Score is Associated with All-Cause Mortality in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. [europepmc]
• All-cause and cause-specific mortality in ANCA-associated vasculitis: overall and according to ANCA type. [europepmc]
• Personalized Medicine in ANCA-Associated Vasculitis ANCA Specificity as the Guide? [europepmc]
• Comorbidities in ANCA-associated vasculitis. [europepmc]
• Cardiac magnetic resonance imaging for the detection of myocardial involvement in granulomatosis with polyangiitis. [europepmc]
• Topic modeling to characterize the natural history of ANCA-Associated vasculitis from clinical notes: A proof of concept study. [europepmc]
• Trend and Geographic Disparities in the Mortality Rates of Primary Systemic Vasculitis in the United States from 1999 to 2019: A Population-Based Study. [europepmc]
• Impact of Cardiovascular Risk Factors on the Occurrence of Cardiovascular Events in Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitides. [europepmc]
• A cohort study to investigate sex-specific differences in ANCA-associated glomerulonephritis outcomes. [europepmc]
• Mortality predictors in ANCA-associated vasculitis: Experience of a Brazilian monocentric cohort of a rheumatology center. [europepmc]
• ANCA Associated Vasculitis Subtypes: Recent Insights and Future Perspectives. [europepmc]
• The effect of achieving serological remission on subsequent risk of relapse, end-stage renal disease and mortality in ANCA-associated vasculitis: a target trial emulation study. [europepmc]
• Diagnostic and Therapeutic Approach in ANCA-Associated Glomerulonephritis: A Review on Management Strategies. [europepmc]
• Relationship Between Gender and 1-Year Mortality in ANCA-Associated Vasculitis Patients: A Single-Center Retrospective Analysis and Meta-Analysis. [europepmc]
• Neutrophils in ANCA-associated vasculitis: Mechanisms and implications for management. [europepmc]
• Plasma Exchange for ANCA-Associated Vasculitis: An International Survey of Patient Preferences. [europepmc]
• Comparative Effectiveness of Rituximab- Versus Cyclophosphamide-Based Remission Induction Strategies in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis for the Risk of Kidney Failure and Mortality. [europepmc]
• Outcomes of remission induction therapy for ANCA-associated vasculitis in the elderly. [europepmc]
• ANCA-associated vasculitis in Ireland: a multi-centre national cohort study. [europepmc]
• Antineutrophil cytoplasmic antibody-associated vasculitis with predominant truncal muscle weakness: a retrospective case series. [europepmc]
• Immune profiling-based targeting of pathogenic T cells with ustekinumab in ANCA-associated glomerulonephritis. [europepmc]